BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Ferlito L, Rampello L. Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology. 1998;37:93-97. [PMID: 9566274 DOI: 10.1159/000026485] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Schaefer M, Engelbrechta MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K. Interferon alpha (IFNα) and psychiatric syndromes. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002;26:731-46. [DOI: 10.1016/s0278-5846(01)00324-4] [Cited by in Crossref: 141] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
2 Lotrich FE. Psychiatric clearance for patients started on interferon-alpha-based therapies. Am J Psychiatry 2013;170:592-7. [PMID: 23732965 DOI: 10.1176/appi.ajp.2013.12121572] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Asnis GM, De La Garza R 2nd. Interferon-induced depression: strategies in treatment. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:808-18. [PMID: 15907352 DOI: 10.1016/j.pnpbp.2005.03.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
4 Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2002;67:311-8. [PMID: 12445491 DOI: 10.1054/plef.2002.0435] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 4.7] [Reference Citation Analysis]
5 Horikawa N, Yamazaki T, Izumi N, Uchihara M. Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. Gen Hosp Psychiatry. 2003;25:34-38. [PMID: 12583926 DOI: 10.1016/s0163-8343(02)00239-6] [Cited by in Crossref: 98] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
6 Lotrich FE. Major depression during interferon-alpha treatment: vulnerability and prevention. Dialogues Clin Neurosci 2009;11:417-25. [PMID: 20135899 [PMID: 20135899 DOI: 10.31887/dcns.2009.11.4/felotrich] [Cited by in Crossref: 12] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kronfol Z, Litman HJ, Back-Madruga C, Bieliauskas LA, Lindsay KL, Lok AS, Fontana RJ; HALT-C Trial Group. No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C. J Affect Disord 2011;129:205-12. [PMID: 20889211 DOI: 10.1016/j.jad.2010.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Lotrich FE, Rabinovitz M, Gironda P, Pollock BG. Depression following pegylated interferon-alpha: characteristics and vulnerability. J Psychosom Res 2007;63:131-5. [PMID: 17662748 DOI: 10.1016/j.jpsychores.2007.05.013] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 4.6] [Reference Citation Analysis]
9 Trask PC, Esper P, Riba M, Redman B. Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. J Clin Oncol 2000;18:2316-26. [PMID: 10829053 DOI: 10.1200/JCO.2000.18.11.2316] [Cited by in Crossref: 125] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
10 Torres-platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain, Behavior, and Immunity 2014;42:50-9. [DOI: 10.1016/j.bbi.2014.05.007] [Cited by in Crossref: 232] [Cited by in F6Publishing: 226] [Article Influence: 29.0] [Reference Citation Analysis]
11 Raison CL, Demetrashvili M, Capuron L, Miller AH. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs. 2005;19:105-123. [PMID: 15697325 DOI: 10.2165/00023210-200519020-00002] [Cited by in Crossref: 331] [Cited by in F6Publishing: 290] [Article Influence: 19.5] [Reference Citation Analysis]
12 Malaguarnera M, Laurino A, Di Fazio I, Pistone G, Castorina M, Guccione N, Rampello L. Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C. J Interferon Cytokine Res. 2001;21:273-278. [PMID: 11429157 DOI: 10.1089/107999001300177457] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
13 Torres-Platas SG, Hercher C, Davoli MA, Maussion G, Labonté B, Turecki G, Mechawar N. Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology. 2011;36:2650-2658. [PMID: 21814185 DOI: 10.1038/npp.2011.154] [Cited by in Crossref: 119] [Cited by in F6Publishing: 123] [Article Influence: 10.8] [Reference Citation Analysis]
14 Gallegos-Orozco JF, Fuentes AP, Gerardo Argueta J, Pérez-Pruna C, Hinojosa-Becerril C, Sixtos-Alonso MS, Cruz-Castellanos S, Gutiérrez-Reyes G, Olivera-Martínez MA, Gutiérrez-Ruiz MC, Kershenobich D. Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003;34:124-9. [PMID: 12700008 DOI: 10.1016/s0188-4409(03)00003-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
15 Dughera L, Battaglia E, Serra AM, Tibaudi D, Buonafede G, Navino M, Schinco P, Tamponi G, Emanuelli G. Human leukocyte interferon-alpha treatment for chronic HCV-related hepatitis in hemophilic patients previously intolerant to other interferons-alpha. Dig Dis Sci 2002;47:427-31. [PMID: 11855562 DOI: 10.1023/a:1013798812144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry. 2005;66:41-48. [PMID: 15669887 DOI: 10.4088/jcp.v66n0106] [Cited by in Crossref: 213] [Cited by in F6Publishing: 83] [Article Influence: 12.5] [Reference Citation Analysis]
17 Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM. Hepatitis C, interferon alfa, and depression. Hepatology. 2000;31:1207-1211. [PMID: 10827143 DOI: 10.1053/jhep.2000.7880] [Cited by in Crossref: 154] [Cited by in F6Publishing: 147] [Article Influence: 7.0] [Reference Citation Analysis]
18 Schmidt F, Janssen G, Martin G, Lorenz R, Loeschke K, Soyka M, Folwaczny C, Schaefer M. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2009;30:1049-59. [DOI: 10.1111/j.1365-2036.2009.04123.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
19 Adler Cohen MA, Jacobson JM. Maximizing life’s potentials in AIDS: A psychopharmacologic update. General Hospital Psychiatry 2000;22:375-88. [DOI: 10.1016/s0163-8343(00)00095-5] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
20 Schäfer A, Wittchen HU, Seufert J, Kraus MR. Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review. Int J Methods Psychiatr Res 2007;16:186-201. [PMID: 18188838 DOI: 10.1002/mpr.229] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
21 Xiong H, Zhang X, Zhang Y, Ma F, Li Y, Li L. An investigation of the prevalence of depressive symptoms in soldiers during military training. Preventive Medicine 2005;41:642-5. [DOI: 10.1016/j.ypmed.2005.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
22 Lotrich FE. Inflammatory cytokine-associated depression. Brain Res 2015;1617:113-25. [PMID: 25003554 DOI: 10.1016/j.brainres.2014.06.032] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 9.1] [Reference Citation Analysis]
23 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
24 Bonaccorso S, Meltzer H, Maes M. Psychological and behavioural effects of interferons: . Current Opinion in Psychiatry 2000;13:673-7. [DOI: 10.1097/00001504-200011000-00034] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
25 Elsayed H, Elsayed M, Arafa M, Elbendary M. Prospective study of psychiatric side effects during antiviral therapy of chronic hepatitis C in an Egyptian sample: . Middle East Current Psychiatry 2012;19:71-7. [DOI: 10.1097/01.xme.0000407891.12614.d0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Malek-ahmadi P. Mood Disorders Associated with Interferon Treatment: Theoretical and Practical Considerations. Ann Pharmacother 2001;35:489-95. [DOI: 10.1345/aph.10172] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
27 Mistler LA, Brunette MF, Marsh BJ, Vidaver RM, Luckoor R, Rosenberg SD. Hepatitis C Treatment for People With Severe Mental Illness. Psychosomatics 2006;47:93-107. [DOI: 10.1176/appi.psy.47.2.93] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
28 Patten SB, Williams JV, Metz LM. Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis. Mult Scler 2008;14:406-11. [PMID: 17986504 DOI: 10.1177/1352458507082942] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
29 Saunders JC, Cookman CA. A Clarified Conceptual Meaning of Hepatitis C-Related Depression: . Gastroenterology Nursing 2005;28:123-9. [DOI: 10.1097/00001610-200503000-00006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
30 Malaguarnera M, Vacante M, Bertino G, Neri S, Malaguarnera M, Gargante MP, Motta M, Lupo L, Chisari G, Bruno CM. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin. J Interferon Cytokine Res. 2011;31:653-659. [PMID: 21923249 DOI: 10.1089/jir.2011.0010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
31 Pan X, Liu W, Deng G, Liu T, Yan J, Tang Y, Dong W, Cui Y, Xu M. Symptoms of Posttraumatic Stress Disorder, Depression, and Anxiety Among Junior High School Students in Worst-Hit Areas 3 Years After the Wenchuan Earthquake in China. Asia Pac J Public Health 2015;27:NP1985-94. [DOI: 10.1177/1010539513488625] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
32 Mazzoran L, Zorat F, Chemello L, Crocè LS, Rigato I, Cavalletto L, Bernardinello E, Tiribelli C, Alberti A, Pozzato G. Human leucocyte interferon-alpha in the treatment of chronic hepatitis C. Dig Liver Dis 2001;33:347-52. [PMID: 11432514 DOI: 10.1016/s1590-8658(01)80090-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Huang Y, Shi X, Li Z, Shen Y, Shi X, Wang L, Li G, Yuan Y, Wang J, Zhang Y, Zhao L, Zhang M, Kang Y, Liang Y. Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder. Neuropsychiatr Dis Treat 2018;14:3329-37. [PMID: 30584306 DOI: 10.2147/NDT.S188340] [Cited by in Crossref: 65] [Cited by in F6Publishing: 30] [Article Influence: 16.3] [Reference Citation Analysis]
34 Spirin NN, Kasatkin DS. The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis. Neurosci Behav Physi 2009;39:25-30. [DOI: 10.1007/s11055-008-9087-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 Castéra L, Constant A, Henry C, Couzigou P. Manifestations psychiatriques au cours du traitement de l’hépatite chronique C. Gastroentérologie Clinique et Biologique 2005;29:123-33. [DOI: 10.1016/s0399-8320(05)80714-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
36 Cassidy EM, Manning D, Byrne S, Bolger E, Murray F, Sharifi N, Wallace E, Keogan M, O’keane V. Acute effects of low-dose interferon-α on serum cortisol and plasma interleukin-6. J Psychopharmacol 2002;16:230-4. [DOI: 10.1177/026988110201600307] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
37 Van Gool AR, Kruit WH, Engels FK, Stoter G, Bannink M, Eggermont AM. Neuropsychiatric side effects of interferon-alfa therapy. Pharm World Sci 2003;25:11-20. [PMID: 12661471 DOI: 10.1023/a:1022449613907] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
38 Tanaka Y, Nagaki M, Tomita E, Murase M, Enya M, Nishigaki Y, Sugihara J, Moriwaki H. Psychoneurological symptoms during interferon therapy in patients with chronic hepatitis: prospective study on predictive use of Cornell Medical Index and electroencephalogram. Liver Int 2004;24:407-12. [DOI: 10.1111/j.1478-3231.2004.0942.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
39 Cozzolongo R, Porcelli P, Cariola F, Giannuzzi V, Lanzilotta E, Gentile M, Sonnante G, Leandro G. Serotonin gene polymorphisms and lifetime mood disorders in predicting interferon-induced depression in chronic hepatitis C. J Affect Disord 2015;183:90-7. [PMID: 26001668 DOI: 10.1016/j.jad.2015.04.056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
40 Fontana RJ, Kronfol Z, Lindsay KL, Bieliauskas LA, Padmanabhan L, Back-Madruga C, Lok AS, Stoddard AM. Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C. Am J Gastroenterol. 2008;103:2766-2775. [PMID: 18721241 DOI: 10.1111/j.1572-0241.2008.02106.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
41 Liu CS, Adibfar A, Herrmann N, Gallagher D, Lanctôt KL. Evidence for Inflammation-Associated Depression. Curr Top Behav Neurosci 2017;31:3-30. [PMID: 27221622 DOI: 10.1007/7854_2016_2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
42 Slyepchenko A, Maes M, Köhler CA, Anderson G, Quevedo J, Alves GS, Berk M, Fernandes BS, Carvalho AF. T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model. Neurosci Biobehav Rev 2016;64:83-100. [PMID: 26898639 DOI: 10.1016/j.neubiorev.2016.02.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
43 Vignau J, Karila L, Costisella O, Canva V. Hépatite C, Interféron α et dépression : principales hypothèses physiopathologiques. L'Encéphale 2005;31:349-57. [DOI: 10.1016/s0013-7006(05)82400-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
44 Tripi S, Soresi M, Di Gaetano G, Carroccio A, Giannitrapani L, Vuturo O, Di Giovanni G, Montalto G. Leucocyte Interferon-alpha for Patients with Chronic Hepatitis C Intolerant to Other alpha-Interferons: . BioDrugs 2003;17:201-5. [DOI: 10.2165/00063030-200317030-00006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
45 Marron MM, Anderson SJ, Garrity J, Reynolds CF 3rd, Lotrich FE. Association of Baseline Sleep Quality With Trajectories of Depressive Symptoms in Patients Undergoing Interferon Treatment. Psychosom Med 2015;77:911-20. [PMID: 26407225 DOI: 10.1097/PSY.0000000000000231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Scotto G, Campanozzi F, D??adduzio A, Grimaldi M, Fazio V. Interferon-?? (IFN??) Daily Dose Versus IFN?? Plus Ribavirin for Treatment-Naive Chronic Hepatitis??? C Patients Infected by Genotype 1b: . BioDrugs 2003;17:281-6. [DOI: 10.2165/00063030-200317040-00007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
47 Pandey GN, Dwivedi Y. What can post-mortem studies tell us about the pathoetiology of suicide? Future Neurol 2010;5:701-20. [PMID: 21436961 DOI: 10.2217/fnl.10.49] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
48 Smith KJ, Norris S, O'Farrelly C, O'Mara SM. Risk factors for the development of depression in patients with hepatitis C taking interferon-α. Neuropsychiatr Dis Treat. 2011;7:275-292. [PMID: 21654873 DOI: 10.2147/NDT.S13917] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
49 Barbaro G, Grisorio B, Fruttaldo L, Bacca D, Babudieri S, Torre D, Francavilla R, Rizzo G, Belloni G, Lucchini A, Annese M, Matarazzo F, Hazra C, Barbarini G. Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study. BioDrugs 2003;17:433-9. [PMID: 14614766 DOI: 10.2165/00063030-200317060-00006] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
50 Mahajan S, Avasthi A, Grover S, Chawla YK. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection. J Psychosom Res 2014;77:109-15. [PMID: 25077851 DOI: 10.1016/j.jpsychores.2014.05.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
51 Turner EH, Blackwell AD. 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: Synergistic mechanisms for normalizing synaptic serotonin. Medical Hypotheses 2005;65:138-44. [DOI: 10.1016/j.mehy.2005.01.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
52 Malaguarnera M, Vicari E, Calogero A, Cammalleri L, Di Fazio I, Gargante MP, Pennisi G, Risino C, Ranno S, Rampello L. Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin. J Interferon Cytokine Res. 2008;28:603-609. [PMID: 18778198 DOI: 10.1089/jir.2008.0021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
53 Yovtcheva SP, Rifai MA, Moles JK, Van der Linden BJ. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics. 2001;42:411-415. [PMID: 11739908 DOI: 10.1176/appi.psy.42.5.411] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 4.3] [Reference Citation Analysis]
54 Lieb K, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Janssen G, Schaefer M. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study. Eur psychiatr 2006;21:204-10. [DOI: 10.1016/j.eurpsy.2004.09.030] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 22.5] [Reference Citation Analysis]
55 de Beaurepaire R, Swiergiel AH, Dunn AJ. Neuroimmune Mediators: Are Cytokines Mediators of Depression? In: Licinio J, Wong M, editors. Biology of Depression. Wiley; 2005. pp. 557-81. [DOI: 10.1002/9783527619672.ch22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
56 Scalori A, Pozzi M, Bellia V, Apale P, Santamaria G, Bordoni T, Redaelli A, Avolio A, Parravicini P, Pioltelli P. Interferon-induced depression: prevalence and management. Dig Liver Dis. 2005;37:102-107. [PMID: 15733522 DOI: 10.1016/j.dld.2004.09.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]